Ambar Protein Industries Promoter Acquires Additional Shares in December

Ambar Protein Industries has witnessed multiple stake increases by its promoter through open market transactions in December. Minouli Pradeepbhai Khetani has made two separate acquisitions during the month, as disclosed under SEBI regulations.

Recent Transaction Details

The promoter's latest acquisition involved 2,488 equity shares representing 0.04% of the company's total share capital through open market transactions on December 19, 2025. This follows an earlier acquisition of 5,177 shares on December 9, 2025.

Parameter:	Latest Transaction	Previous Transaction
Shares Acquired:	2,488 equity shares	5,177 equity shares
Percentage Acquired:	0.04%	0.09%
Transaction Date:	December 19, 2025	December 9, 2025
Mode of Acquisition:	Open Market	Open Market
Acquirer:	Minouli Pradeepbhai Khetani (Promoter)	Minouli Pradeepbhai Khetani (Promoter)

Shareholding Pattern Evolution

The cumulative acquisitions have resulted in a progressive increase in the promoter's total shareholding in the company. The promoter's stake has increased from 9.54% to 9.67% through these December transactions.

Holding Period:	Number of Shares	Percentage Holding
Initial Holding:	5,48,556 shares	9.54%
After First Acquisition:	5,53,733 shares	9.63%
After Latest Acquisition:	5,56,221 shares	9.67%

Company's Share Capital Structure

Ambar Protein Industries Limited maintains a consistent equity share capital structure throughout these transactions. The company's total equity share capital remains unchanged at ₹5.75 crores, consisting of 57,50,000 equity shares of ₹10 each.

The company's shares are listed on BSE Limited under scrip code 519471. The total diluted share capital also stands at ₹5.75 crores, consisting of 57,50,000 equity shares of ₹10 each, indicating no outstanding convertible securities or warrants.

Regulatory Compliance

Both disclosures were made in compliance with SEBI regulations governing substantial acquisition of shares and takeovers under Regulation 29(2). The promoter fulfilled the mandatory disclosure requirements by notifying both BSE Limited and the company about the transactions within the stipulated timeframe. This transparency ensures that all stakeholders are informed about changes in the promoter's shareholding pattern.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.77%	-13.05%	-26.31%	-52.56%	+1.10%	+2,587.07%

Ambar Protein Industries Limited , a player in the protein industry, has released its unaudited financial results for the second quarter of fiscal year 2026, ending September 30, 2025. The company's performance shows a mixed picture with a slight decline in revenue and a more pronounced drop in profitability compared to the previous quarter.

Revenue and Profitability

The company reported a total income of Rs 11,314.95 lakhs for Q2 FY2026, marking a decrease from Rs 11,746.31 lakhs in the previous quarter. This represents a quarter-on-quarter decline of 3.67%. The net profit for the period stood at Rs 200.18 lakhs, down from Rs 274.12 lakhs in the prior quarter, indicating a more substantial decrease of 26.97%.

Earnings Per Share

The basic earnings per share (EPS) for Q2 FY2026 was Rs 3.48, compared to Rs 4.77 in the previous quarter, reflecting the decline in profitability.

Financial Position

As of September 30, 2025, Ambar Protein Industries' balance sheet showed some changes compared to the end of the previous fiscal year:

Particular	As at 30.09.2025	As at 31.03.2025	Change
Total Assets	7,034.49	7,050.38	-0.22%
Non-Current Assets	2,319.28	2,216.42	+4.64%
Current Assets	4,715.21	4,833.95	-2.46%
Total Equity	3,747.64	3,472.51	+7.92%
Non-Current Liabilities	212.84	252.96	-15.86%
Current Liabilities	3,074.01	3,324.91	-7.55%

Notable changes include:

A slight decrease in total assets
An increase in non-current assets, possibly due to capital investments
A reduction in current assets, potentially impacting working capital
A significant increase in total equity, strengthening the company's financial position
Reductions in both non-current and current liabilities, indicating improved debt management

Borrowings and Liquidity

The company's current borrowings decreased to Rs 2,286.04 lakhs from Rs 2,579.28 lakhs as of March 31, 2025, suggesting improved liquidity or debt repayment. Cash and cash equivalents stood at Rs 38.91 lakhs, down from Rs 113.10 lakhs at the end of the previous fiscal year.

Auditor's Review

The limited review conducted by the company's auditors found no material misstatements in the financial results. The results were prepared in accordance with Indian Accounting Standards (Ind AS) and other recognized accounting principles.

Outlook

While Ambar Protein Industries has experienced a decline in revenue and profitability this quarter, the company's improved equity position and reduced liabilities may provide a foundation for future growth. Investors and stakeholders will likely be watching closely to see how the company navigates the challenges reflected in this quarter's results and capitalizes on its strengthened balance sheet in the coming periods.

The company's board of directors approved these unaudited financial results at their meeting held on October 17, 2025, demonstrating their commitment to timely financial reporting and transparency with stakeholders.